Gregory Norden's Net Worth

$6.98 Million

Estimate Recalculated Apr 19, 2024 03:26PM EST

Who is Gregory Norden?

Gregory Norden has an estimated net worth of $6.98 Million. This is based on reported shares across multiple companies, which include Zoetis Inc., Royalty Pharma plc, Praxis Precision Medicines, Inc., NanoString Technologies Inc, Entasis Therapeutics Holdings Inc., HUMAN GENOME SCIENCES INC, WYETH, and K-V Pharmaceutical Co.

SEC CIK

Gregory Norden's CIK is 0001405104

Past Insider Trading and Trends

2023 was Gregory Norden's most active year for acquiring shares with 9 total transactions. Gregory Norden's most active month to acquire stocks was the month of January. 2009 was Gregory Norden's most active year for disposing of shares, totalling 14 transactions. Gregory Norden's most active month to dispose stocks was the month of January. 2017 saw Gregory Norden paying a total of $199,997.70 for 12,246 shares, this is the most they've acquired in one year. In 2021 Gregory Norden cashed out on 13,496.146 shares for a total of $1,088,511.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Zoetis Inc. (ZTS) Snapshot price: $197.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.21K
—
—
0
Feb 21
Form 4
+46.92%
1.1K
$197.32
-$72,416.44
3.43K
Feb 10
Form 4
+91.79%
1.12K
$195.75
-$73,406.25
2.34K
Feb 8
Form 4
—
0
—
—
0
Feb 6
Form 4/A
-90.12%
-5.32K
—
—
583.19
May 15 - May 19
Form 4
-90.12%
-5.32K
—
—
583.19
May 5
Form 4
∞
1.22K
$158.33
-$64,598.64
1.22K
Feb 11
Form 4
—
0
—
—
0
Feb 8
Form 4
∞
2K
$198.87
-$133,441.77
2K
Feb 12
Form 4
—
0
—
—
0
Feb 8
Form 4
-53.58%
-4.50K
$216.07
-$972,315.00
3.9K
Nov 5
Form 4
+33.01%
2.08K
$166.71
-$116,196.87
8.39K
Feb 13
Form 4
—
0
—
—
0
Feb 10
Form 4
-47.69%
-5.62K
—
—
6.16K
Apr 29
Form 4
+30.80%
2.77K
$144.17
-$133,933.93
11.78K
Feb 14
Form 4
—
0
—
—
0
Feb 11
Form 4
+52.69%
3.11K
$94.91
-$98,801.31
9.01K
Feb 19
Form 4
—
0
—
—
0
Feb 12
Form 4
+91.87%
2.83K
$81.67
-$77,259.82
5.9K
Feb 27
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Mar 4
Form 4
+38.37%
12.72
—
—
45.86
Feb 3
Form 4
+49.92%
11.04
—
—
33.14
Nov 6
Form 4
+0.74%
22.11
—
—
3.02K
Jul 24 - Sep 26
Form 4
∞
3K
$26.00
$78,000.00
3K
Feb 6
Form 4
—
0
—
—
0
Jan 31
Form 3
—
0
—
—
0
No matching records found

Royalty Pharma plc (RPRX) Snapshot price: $30

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.66%
7.75K
—
—
64.44K
Jun 23
Form 4
+12.56%
6.33K
—
—
56.7K
Jun 24
Form 4
+12.83%
5.73K
—
—
50.37K
Jun 25
Form 4
+25.00%
8.93K
—
—
44.64K
Jun 15 - Jun 18
Form 4
∞
35.72K
—
—
35.72K
Jun 15
Form 3
—
0
—
—
0
No matching records found

Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $44.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
May 26
Form 4
∞
2.83K
—
—
2.83K
May 12
Form 4
—
0
—
—
0
Jun 8
Form 3
—
0
—
—
0
No matching records found

NanoString Technologies Inc (NSTG) Snapshot price: $0.08

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
Form 4
+45.60%
14.85K
—
—
47.42K
Jun 17
Form 4
+36.84%
8.77K
$8.45
$74,089.60
32.57K
Apr 27
Form 4
+110.62%
12.5K
$9.84
$123,000.00
23.8K
Mar 7
Form 4
+52.50%
3.89K
—
—
11.3K
Jun 16 - Jun 17
Form 4
+292.06%
5.52K
—
—
7.41K
Jun 15 - Jun 16
Form 4
—
0
$30.12
-$586,912.32
1.89K
Dec 7
Form 4
-84.10%
-10.00K
$38.83
-$388,250.00
1.89K
Aug 13
Form 4
+18.90%
1.89K
—
—
11.89K
Jun 15 - Jun 16
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Mar 25
Form 4
∞
10K
$6.93
$69,300.00
10K
Mar 13
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jul 10
Form 3
—
0
—
—
0
No matching records found

Entasis Therapeutics Holdings Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found